Codelivery of Genistein and miRNA-29b to A549 Cells Using Aptamer-Hybrid Nanoparticle Bioconjugates
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Codelivery of Genistein and miRNA-29b to A549 Cells Using Aptamer-Hybrid Nanoparticle Bioconjugates
Authors
Keywords
-
Journal
Nanomaterials
Volume 9, Issue 7, Pages 1052
Publisher
MDPI AG
Online
2019-07-23
DOI
10.3390/nano9071052
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of MUC1-Aptamer Functionalized Hybrid Nanoparticles for Targeted Delivery of miRNA-29b to Nonsmall Cell Lung Cancer
- (2018) Maryna Perepelyuk et al. MOLECULAR PHARMACEUTICS
- Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins
- (2016) Sunday Shoyele et al. International Journal of Nanomedicine
- Genistein inhibits A549 human lung cancer cell proliferation via miR-27a and MET signaling
- (2016) Yang Yang et al. Oncology Letters
- An aptamer targeting shared tumor-specific peptide antigen of MAGE-A3 in multiple cancers
- (2015) Chin-Yu Wang et al. INTERNATIONAL JOURNAL OF CANCER
- MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells
- (2015) Akriti Kharbanda et al. Oncotarget
- Influence of Surface Modification and the pH on the Release Mechanisms and Kinetics of Erlotinib from Antibody-Functionalized Chitosan Nanoparticles
- (2014) Asha R. Srinivasan et al. INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
- Stable and Efficient Transfection of siRNA for Mutated KRAS Silencing Using Novel Hybrid Nanoparticles
- (2014) A. Lakshmikuttyamma et al. MOLECULAR PHARMACEUTICS
- Genistein enhances the effect of cisplatin on the inhibition of non-small cell lung cancer A549 cell growth in vitro and in vivo
- (2014) DEZHI LIU et al. Oncology Letters
- Studies on stabilization mechanism and stealth effect of poloxamer 188 onto PLGA nanoparticles
- (2013) Darshana Jain et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- MiRNA-29: A microRNA Family with Tumor-Suppressing and Immune-Modulating Properties
- (2013) M.J. Schmitt et al. CURRENT MOLECULAR MEDICINE
- The role of miRNA-29 family in cancer
- (2013) Yang Wang et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Involvement of epigenetics and microRNA-29b in the urethane induced inception and establishment of mouse lung tumors
- (2013) Manuraj Pandey et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Investigation of the Stability and Cellular Uptake of Self-Associated Monoclonal Antibody (MAb) Nanoparticles by Non-Small Lung Cancer Cells
- (2013) Asha R. Srinivasan et al. MOLECULAR PHARMACEUTICS
- Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
- (2013) Yun Wu et al. Molecular Therapy-Nucleic Acids
- Self-Associated Submicron IgG1 Particles for Pulmonary Delivery: Effects of Non-ionic Surfactants on Size, Shape, Stability, and Aerosol Performance
- (2012) Asha R. Srinivasan et al. AAPS PHARMSCITECH
- Cellular Uptake and Intracellular Trafficking of Antisense and siRNA Oligonucleotides
- (2011) Rudolph L. Juliano et al. BIOCONJUGATE CHEMISTRY
- Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro
- (2011) Chenchen Yu et al. PLoS One
- Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression
- (2010) Gail T. McDonald et al. EXPERIMENTAL CELL RESEARCH
- MicroRNA 29b functions in acute myeloid leukemia
- (2009) R. Garzon et al. BLOOD
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
- (2008) S. Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More